We're sorry but this page doesn't work properly without JavaScript enabled. Please enable it to continue.
Feedback

Recombinant DENV 2 NS5: An Effective Antigen for Diagnosis of Dengue Infection

00:00

Formal Metadata

Title
Recombinant DENV 2 NS5: An Effective Antigen for Diagnosis of Dengue Infection
Title of Series
Number of Parts
34
Author
License
CC Attribution 3.0 Unported:
You are free to use, adapt and copy, distribute and transmit the work or content in adapted or unchanged form for any legal purpose as long as the work is attributed to the author in the manner specified by the author or licensor.
Identifiers
Publisher
Release Date
Language

Content Metadata

Subject Area
Genre
Abstract
Dengue fever as one of the most important mosquito-borne disease worldwide which approximately half of the world's population is at risk presenting several degrees of symptoms, including life-threatening dengue haemorrhagic fever (DHF) and dengue shock syndrome (DSS). Dengue virus (DENV) belongs to the Flaviviridae family, and are classified into four immunologically distinct serotypes, DENV 1 to 4. Although, there is no specific treatment, early diagnosis is important for proper medical care to minimize mortality, and for prompt initiation of public health control measures. There are some diagnostic tests targeting NS1 antigen in commercial, but these methods need all the four serotypes of NS1. NS1 and NS5 are translated and appear almost simultaneously. Our work is mainly based on the fact that NS5 is the most conservative protein among all the flavivirus family, and its’ RNA dependent RNA polymerase (RdRp) domain plays a vital role in viral RNA replication. Itis a prospective biomarker for dengue infection. In this study, we constructed the DENV 2 NS5 full length and DENV2 NS5 C-terminus RdRp domain (NS5-C70) expression plasmids, a 104 kDa fragment of NS5, and a 70 kDa fragment of NS5-C70 were respectively expressed in Escherichia coli. These two purified recombinant products reacted with sera of patients infected with dengue virus in an enzyme-linked immunosorbent assay with significantly higher optical density values compared with the control sera. The recombinant DENV 2 NS5 showed strong reactivity for any of the four serotypes, while the NS5-C70 fragment showed strong reactivity for DENV 2 and 4. It is suggested DENV 2 NS5 can detect all the four serotypes patients, greatly reducing the cumbersome procedures with four viral types of antigens in early diagnostic process. The recombinant NS5 protein might be an effective antigen for dengue diagnosis, and NS5-C70 also can be used for auxiliary diagnosis.
Keywords
Computer animation
Transcript: English(auto-generated)
I've known everyone. I feel really honored to stand here. And the subject of my presentation
is the recombinant dengue virus to NS5, an effective antigen for diagnosis of dengue infections. Dengue virus belongs to flavor diol families and are classified in two, four
immunologically distinct serotypes can cause disease ranging from nonspecific fever illness to classic dengue fever, dengue hemorrhagic fever, and dengue shock syndrome. Among the DHF and the DSS are often fatal. And dengue fever is endemic in tropic and
climates. There are nearly 390 million dengue virus infections occur annually. And over the past decades, dengue fever has separated from less than nine to currently about 128
academic countries. Dengue virus is transmitted by female mosquitoes, mainly age, aegypti, and angiopictus. All the stereotypes can be transmitted from human to human.
And individuals infected by any one stereotype will have lifelong immunity against re-infection of the same stereotype, but only partially protected from other stereotypes.
Infections with a different serotype are associated with a higher risk of severe complications such as DHF and the DSS due to ADE infection. And the dengue virus is also
a prototype of other flu viruses. For example, the Zika virus, this homology raises the risk of cross-reactive immune responses and subsequent ADE infections in the case of secondary infections
or immunization of the individuals. And the recent outbreak of Zika virus epidemics has raised a growing concern with both viruses. Around early 2016, the first dengue vaccine has been marketed in several countries, but
accumulating reports indicate that this vaccine did not achieve the design effect. And it should be conscious that this vaccine might cause ADE effect in populations.
Here are some prevention and control strategies proposed and practiced in dengue endemic regions,
but none of them achieved the effect. Dengue diagnosis is based on epidemic information, clinical symptoms, and combined laboratory detections. Although there is no specific treatment, early diagnosis is important for proper medical care to minimize mortality and
for proper initiation of public healthy control measures. There are several approaches to establish laboratory diagnosis, and these are of different specificity and sensitivity and require more than
two detection indicators. Any single indicator is not enough to provide reliable and effective results. And there are some rapid diagnosis of antigen detection and antibody detection
targeting NS1 are now commercially available, but both of them require all the four serotypes
or recombinant NS1. Why are we interested in NS5? Dengue virus NS5 are highly conserved among serotypes that have not been found to participate in the ADE phenomenon.
Dengue single open reading framework includes a polyprotein precursor, which is created by cellular and viral proteins in two structural and nonstructural proteins. NS1 and NS5 appear almost at the same time, and NS5 consists of two major functional domains,
the N-terminal I-methyltransferase domain and the C-terminal I-dependent I-polymerase domain. And the NS5-IDRP domain plays a vital role in viral RNA replications like
other polymerases. Dengue virus RNA processes an architecture that is conserved across different classes and families of polymerases. This structure mimics a half-closed right hand
with three subdomains termed finger, palm, and thumb. NS5 potential to be an antiviral target and a biomarker of dengue diagnosis. We constructed an NS5-IDRP domain
expression plasmid and an NS5-4 length expression plasmid and expressed a purified
70 kilo fragment and NS5-4 length fragment in E. coli. And these two purified recombinant
products reacted with sero of patients infected with dengue virus in an elastin with higher OD index compared with the control sera. And the recombinant dengue virus 2NS5
showed strong reactivity for any of the four serotypes, while the 70 kilo fragment shows strong reactivity for dengue virus 2 and 4. And dengue virus 2NS5 might be an effective
antigen for dengue diagnosis and the 70 kilo fragment also can be used for auxiliant diagnosis. Thank you.